Dolutegravir Resistance in Malawi’s National HIV Treatment Program
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac148
Abstract: Abstract Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on dolutegravir-based antiretroviral therapy (November 2020–September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa,… read more here.
Keywords: resistance malawi; dolutegravir resistance; malawi national; national hiv ... See more keywords